文锋, 王伟, 尚立群, 李学昌, 李军, 刘军强. 恩度联合NP方案治疗非小细胞肺癌临床疗效观察[J]. 实用临床医药杂志, 2011, (13): 79-80. DOI: 10.3969/j.issn.1672-2353.2011.13.029
引用本文: 文锋, 王伟, 尚立群, 李学昌, 李军, 刘军强. 恩度联合NP方案治疗非小细胞肺癌临床疗效观察[J]. 实用临床医药杂志, 2011, (13): 79-80. DOI: 10.3969/j.issn.1672-2353.2011.13.029
WEN Feng, WANG Wei, SHANG Li-qun, LI Xue-chang, LI Jun, LIU Jun-Jiang. Observation of short term effects of endostar combined with NP regimen for Non-Small Cell Lung Cancer[J]. Journal of Clinical Medicine in Practice, 2011, (13): 79-80. DOI: 10.3969/j.issn.1672-2353.2011.13.029
Citation: WEN Feng, WANG Wei, SHANG Li-qun, LI Xue-chang, LI Jun, LIU Jun-Jiang. Observation of short term effects of endostar combined with NP regimen for Non-Small Cell Lung Cancer[J]. Journal of Clinical Medicine in Practice, 2011, (13): 79-80. DOI: 10.3969/j.issn.1672-2353.2011.13.029

恩度联合NP方案治疗非小细胞肺癌临床疗效观察

Observation of short term effects of endostar combined with NP regimen for Non-Small Cell Lung Cancer

  • 摘要: 目的 观察恩度联合NP方案 (长春瑞宾+顺铂)治疗晚期非小细胞肺癌的近期临床疗效,评价恩度临床应用的安全性和耐受性.方法 比较恩度联合NP组(联合化疗组) 和 NP组 (单纯化疗组)疗效.结果 联合化疗组有效率为25.58%,单纯化疗组有效率为9.76%,毒副反应主要有白细胞减少、恶心、呕吐、乏力等.结论 恩度与NP方案联合应用,能明显提高晚期非小细胞肺癌的有效率,且安全性较好.

     

/

返回文章
返回